Cell Therapy Group

What Cell Therapy Group does

Cell Therapy Group (CTG) is a boutique strategic management consulting firm serving the cell-based regenerative medicine sector, founded in 2008 by Lee Buckler. The firm provides business-focused services including business development, strategy development, mergers & acquisitions support, financings, turnaround and restructuring, operational buildout, market analysis, third-party contract service analysis and oversight, and project management. CTG's stated positioning targets companies in transition due to growth, distress, or disruption, and the practice has engaged both founder-stage startups and top-10 pharmaceutical companies across Europe, Israel, North America, and Asia.

CTG's core service offering is built on the founder's 20-plus years of domain experience rather than a proprietary technology platform or productized methodology. Its service mix has progressively extended beyond pure cell therapy into cell cultured meat, with particular emphasis on the interface between the two industries — an emerging cross-sector adjacency in cultivated bioproducts. The firm does not publicize pricing or contract structures; engagements appear to begin with non-billable discovery conversations before any fees are incurred, and client acquisition is described as relationship- and referral-driven rather than digital-marketing-led.

In 2022, CTG was merged into HighMont Advisors, Inc., a strategic operating parent that aggregates management consulting services for companies in transition. Following the merger, CTG operates as part of HighMont Advisors' portfolio while retaining its brand and sector focus; the firm remains privately held with no disclosed revenue, headcount breakdown, ownership percentages, or cap-table detail. Customer base is segmented across bio-therapeutic companies, device/service/tools/reagent companies, investors, non-profits, and fellow consultants — a horizontal segmentation spanning the full cell therapy ecosystem.

Name

Cell Therapy Group

Legal name

Cell Therapy Group

Website

https://celltherapygroup.com

Company type

Private

Founded year

2008

Operating status

Acquired

Headcount range

1–10 employees

Short description

Cell Therapy Group is a boutique consulting firm founded in 2008 that provides strategic management services — business development, M&A, financings, turnaround, market analysis — to bio-therapeutic, device, and investor clients in the cell therapy and cultured meat sectors, now operating under HighMont Advisors following a 2022 merger.

Ownership category

akta.pro rank

Product category

Biotech Consulting Services

NAICS

Management Consulting Services (54161), Other Scientific and Technical Consulting Services (54169), Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Services-Management Consulting Services (8742), Services-Health Services (8000)

akta.pro primary industry

Cell & Gene Therapy Chain-of-Identity/Chain-of-Custody Logistics (HLAGAMAE)

akta.pro secondary industry

Cell Therapy CDMO (HLAGABAD)

Keywords

• Cell therapy consulting
• Regenerative medicine advisory
• Biotech strategy consulting
• Pharma mergers acquisitions
• Cultured meat consulting

Headquarters

HQ city

North Vancouver

HQ country

Canada

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales

Revenue model

1. Strategic Management Consulting: Provides business development, strategy development, mergers & acquisitions, financings, turnaround & restructuring, operational buildout, market analysis, and related consulting services. Revenue is generated through professional consulting engagements with clients in the cell therapy and cultured meat sectors.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

Cell Therapy Group (CTG) is a strategic management consulting firm serving the cell-based regenerative medicine and cultured meat sectors. It delivers business development, strategy development, mergers & acquisitions, financings, turnaround & restructuring, operational buildout, market analysis, third-party contract service analysis/selection/oversight, and project management services to bio-therapeutic companies, device and reagent suppliers, investors, and non-profit organizations.

Product overview

Cell Therapy Group (CTG) offers a unified suite of strategic consulting services focused on the cell therapy and cell cultured meat sectors. The core offering encompasses business development, strategy development, mergers & acquisitions support, financings, turnaround & restructuring, operational buildout, market analysis, and project management services. CTG was merged into HighMont Advisors, Inc. in 2022 as part of a growing roster of strategic management consulting services.

Differentiator

Problem solved

Functional benefit

Products and services

• Strategic Management Consulting Services Strategic management consulting for companies in the cell therapy, regenerative medicine, and cultured meat sectors, covering business development, strategy development, mergers & acquisitions, financings, turnaround & restructuring, operational buildout, market analysis, third-party contract service analysis/selection/oversight, and project management.

Segments5 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• HighMont Advisors, Inc.coreStrategic or Co-development Partner · 1 January 2022In 2022, Cell Therapy Group was merged into HighMont Advisors, Inc. to expand the business and add it to a growing roster of strategic management consulting services focused on supporting companies in transition. This represents a corporate merger and integration into HighMont Advisors' portfolio of consulting services.

Scale indicators2 records

Recent moves5 records

Expansion highlights4 records

Broad incumbents

• ZS Associates: Global management consulting firm with a deep pharma and biotech practice covering strategy, sales, and operations across the life sciences value chain. Comparable to CTG for biopharma strategy and commercial work, though at much larger scale and broader portfolio.
• Charles River Associates: Global consulting firm with a dedicated life sciences practice providing strategy, economic, and litigation support to pharma and biotech clients. Comparable to CTG at the life sciences strategy and transactions layer, but with vastly greater scale and broader service breadth.
• McKinsey & Company (Biopharma practice): Global management consulting firm with a substantial biopharma and advanced therapies practice serving top pharma and biotech clients on strategy, M&A, and operations. Comparable to CTG for cell therapy strategy and corporate development work but at vastly larger scale and broader service scope.
• Syneos Health Consulting: Biopharma services organization offering commercial, strategic, and clinical consulting alongside broader CRO capabilities. Comparable to CTG for life sciences strategy and commercialization advisory, with a deeper operational footprint across clinical and commercial services.
• Boston Consulting Group (Biopharma practice): Global management consulting firm with a dedicated biopharma and biotech practice covering strategy, M&A, and operations for life sciences clients. Comparable to CTG in the strategy and corporate development layer for cell therapy clients but at global scale.

Direct peers

• Health Advances: Strategy consulting firm exclusively focused on life sciences, advising therapeutics, medtech, and diagnostics clients on commercial strategy, M&A, and corporate development. Comparable to CTG due to its specialist life sciences consulting model and advanced therapy exposure.
• Locust Walk: Life sciences-focused transaction advisory and strategic consulting firm supporting biotech and advanced therapy companies with financings, partnerships, and M&A. Closely comparable to CTG given its cell/gene therapy deal advisory focus and similar boutique client mix.
• Triangle Insights Group: Boutique life sciences strategy consulting firm serving biotech, pharma, and medtech clients with commercial and corporate strategy engagements. Comparable to CTG in its boutique specialist positioning within life sciences advisory.
• Alacrita Consulting: A boutique life sciences consulting firm offering strategic, commercial, and operational advisory to pharma, biotech, and advanced therapy clients. Directly comparable to CTG given its specialized cell/gene therapy and biologics advisory practice and similar boutique model.
• Back Bay Life Science Advisors: Life sciences-focused advisory firm providing strategy, financing, and transaction support to therapeutics, medtech, and digital health companies. Comparable to CTG due to its specialist life sciences focus and deal advisory orientation serving cell therapy and emerging biotech.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/cell-therapy-group

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cell Therapy Group